HC orders probe by ACP in cataract surgeries which went wrong

Image
Press Trust of India Ahmedabad
Last Updated : Feb 14 2017 | 10:07 PM IST
The Gujarat High Court today directed the government to transfer to an ACP-rank officer the probe in a case, where four persons lost their eyesight after undergoing cataract surgeries at a civic hospital last year.
Justice J B Pardiwala ordered the state government to hand over the case to the ACP-level officer, and said it would be overseen by a Deputy Commissioner of Police.
The court asked for the probe report in a month and said the charge sheet shall not be filed without its consent.
It also asked the police to take into consideration a report filed by Food and Drugs Laboratory (FDL) at Vadodara which said the antiseptic drug manufactured by Gujarat Pharma (used in the surgeries) was of standard quality and no bacteria was found in it.
The role of LG Hospital's staff should also be examined, the court said, while hearing applications filed by Gujarat Pharma and the distributor firm Dynamic Marketing House, seeking quashing of FIR in the case.
The FIR cited findings of LG Hospital, NHL Medical College and BJ Medical College -- all run by Ahmedabad Municipal Corporation -- that the liquid antiseptic used in operations was infected with harmful bacteria.
The manufacturer and the distributor were thus responsible for adulterated drug, the findings said, absolving the medical staff at the hospital.
The sub-inspector of Maninagar police station was looking into the FIR, filed five months after the incident, under sections 274 (adulteration of drugs), 275 (sale of adulterated drug), and 338 (causing grievous hurt by act endangering life) of IPC.
FDL, in its report, however, said the drugs used in the operations complied with Drugs and Cosmetics Rules.
The four persons who underwent cataract operations at LG Hospital here on March 11 last year subsequently complained of loss of vision.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 14 2017 | 10:07 PM IST

Next Story